We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZIO
3851
DELISTED
VIZIO Holding Corp.
VZIO
$15K ﹤0.01%
1,637
-4,194
-72% -$37.9K
CIZN
3852
DELISTED
Citizens Holding Co.
CIZN
$15K ﹤0.01%
1,236
-421
-25% -$6.02K
ABSI icon
3853
Absci
ABSI
$1.58B
$14K ﹤0.01%
8,489
-1,372
-14% -$3.32K
ACEL icon
3854
Accel Entertainment
ACEL
$1.01B
$14K ﹤0.01%
1,506
+886
+143% +$7.96K
ACR
3855
ACRES Commercial Realty
ACR
$102M
$14K ﹤0.01%
1,412
-535
-27% -$5.05K
ACRV icon
3856
Acrivon Therapeutics
ACRV
$83.5M
$14K ﹤0.01%
1,092
+933
+587% +$15.7K
ADV icon
3857
Advantage Solutions
ADV
$420M
$14K ﹤0.01%
363
-1,193
-77% -$67.4K
AFMD
3858
DELISTED
Affimed
AFMD
$14K ﹤0.01%
1,841
-327
-15% -$3.27K
ALTI icon
3859
AlTi Global
ALTI
$444M
$14K ﹤0.01%
1,093
+1,091
+54,550% +$11K
AMCX icon
3860
AMC Global Media
AMCX
$510M
$14K ﹤0.01%
815
-1,365
-63% -$25.5K
ANIX icon
3861
Anixa Biosciences
ANIX
$108M
$14K ﹤0.01%
3,393
+3,190
+1,571% +$14K
ATLC icon
3862
Atlanticus Holdings
ATLC
$1.56B
$14K ﹤0.01%
513
-3,012
-85% -$90.6K
BCML icon
3863
BayCom
BCML
$339M
$14K ﹤0.01%
832
+386
+87% +$7.4K
BLV icon
3864
Vanguard Long-Term Bond ETF
BLV
$5.7B
$14K ﹤0.01%
189
+100
+112% +$7.56K
BMRA icon
3865
Biomerica
BMRA
$4.88M
$14K ﹤0.01%
968
+759
+363% +$16.4K
BNED icon
3866
Barnes & Noble Education
BNED
$421M
$14K ﹤0.01%
+93
New +$18.7K
BSRR icon
3867
Sierra Bancorp
BSRR
$532M
$14K ﹤0.01%
827
+270
+48% +$5.43K
BZH icon
3868
Beazer Homes USA
BZH
$872M
$14K ﹤0.01%
880
+746
+557% +$11.1K
CENN icon
3869
Cenntro
CENN
$8.63M
$14K ﹤0.01%
50
+13
+35% +$4.19K
CLSM icon
3870
Exchange Listed Funds Trust ETC Cabana Target Leading Sector Moderate ETF
CLSM
$99.8M
$14K ﹤0.01%
+704
New +$14.3K
CRF
3871
Cornerstone Total Return Fund
CRF
$1.14B
$14K ﹤0.01%
1,887
+1,683
+825% +$12.5K
CRVO icon
3872
CervoMed
CRVO
$36.9M
$14K ﹤0.01%
2,213
+341
+18% +$3.02K
CSTL icon
3873
Castle Biosciences
CSTL
$905M
$14K ﹤0.01%
625
+160
+34% +$3.91K
DOUG icon
3874
Douglas Elliman
DOUG
$185M
$14K ﹤0.01%
4,629
+546
+13% +$2.18K
EBF icon
3875
Ennis
EBF
$559M
$14K ﹤0.01%
658
-672
-51% -$14.4K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.